The competition for developer attention in the blockchain space is intense, especially with the emergence of Layer 2 solutions and the recent SEC ruling on Bitcoin ETF. Injective Labs, creators of the high-speed Injective Protocol, have introduced inEVM, their own Ethereum Virtual Machine (EVM) Layer 2 roll-up. InQubeta (QUBE), a new blockchain ICO player, is also gaining traction for its support of AI tech startups. Injective's inEVM promises true interoperability across major blockchains like Ethereum, Cosmos, and Solana, catering to Ethereum developers with fast speeds and low fees. InQubeta, on the other hand, offers a unique approach by allowing AI startups to tokenize investment opportunities as NFTs, attracting significant investor interest. Both projects show promise in their respective fields, with Injective focusing on blockchain development efficiency and InQubeta revolutionizing AI startup funding through NFTs. Read more AI-generated news on: https://app.chaingpt.org/news